NCT00302523View on ClinicalTrials.gov

Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2009

Conditions
Idiopathic Membranous Nephropathy
Interventions
DRUG

Tacrolimus

FK506,0.1mg/kg/d

Trial Locations (2)

210002

Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine, Nanjing

Research Institute of Nephrology, Jinling Hospital, Nanjing

All Listed Sponsors
lead

Nanjing University School of Medicine

OTHER

NCT00302523 - Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy | Biotech Hunter | Biotech Hunter